Brainard Capital Management LLC Inovio Pharmaceuticals, Inc. Transaction History
Brainard Capital Management LLC
- $131 Billion
- Q1 2023
A detailed history of Brainard Capital Management LLC transactions in Inovio Pharmaceuticals, Inc. stock. As of the latest transaction made, Brainard Capital Management LLC holds 16,666 shares of INO stock, worth $140,494. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,666
Previous 16,666
-0.0%
Holding current value
$140,494
Previous $26 Million
47.44%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding INO
# of Institutions
14Shares Held
292KCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ148KShares$1.25 Million0.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ86.4KShares$728,0650.0% of portfolio
-
Tiaa, Fsb St. Louis, MO14.4KShares$121,2480.0% of portfolio
-
Personal Capital Advisors Corp11.3KShares$95,2590.0% of portfolio
-
Prime Capital Investment Advisors, LLC Overland Park, KS10.2KShares$85,7490.0% of portfolio
About INOVIO PHARMACEUTICALS, INC.
- Ticker INO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 249,400,000
- Market Cap $2.1B
- Description
- Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...